# Astellas Pharma Japan Pension Scheme

Astellas Pharma Japan Pension Scheme is a Pension Fund based in Tokyo, Japan.

## Overview

- **Organization type:** Pension Fund
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** Tokyo, Japan
- **Founded:** 1981
- **Assets under management:** 715 (Altss estimate)
- **Website:** https://astellas.com
- **LinkedIn:** linkedin.com/company/astellas-pharma-ltd.

## Regulatory record

- **Reports private funds:** No

## About

Astellas Pharma Japan Pension Scheme serves as the corporate defined-benefit plan for Astellas Pharma Inc., the entity formed by the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. The plan maintains a target IRR of 3 percent and holds currency exposure in JPY, USD and EUR. Deployment spans infrastructure funds covering toll roads, ports and pipelines in emerging nations, plus separate allocations to commodities and natural resources. Confirmed positions include a limited-partner commitment to Partners Innovation Fund in biotechnology. Geographic reach centers on Japan with additional exposure across global developed and developing markets. The scheme classifies alternative investments as low-liquidity assets and works with advisors including Mass General Brigham Innovation and Mass General Brigham Ventures. It maintains information services from Bloomberg. No named investment committee or recent operational events appear in available records. Governance ties directly to the sponsor Astellas Pharma Inc., with legacy relationships to the two predecessor pharmaceutical companies that merged to create the parent.

## Sectors

- Infrastructure
- Commodities
- Natural Resources
- Biotechnology

## Questions

### Who sponsors the Astellas Pharma Japan Pension Scheme?

Astellas Pharma Inc. sponsors the scheme as its corporate defined-benefit plan for Japanese employees.

### What asset classes receive allocations?

The scheme allocates to infrastructure funds, commodities and natural resources, with at least one biotechnology co-investment.

### Does the scheme apply ESG criteria?

Yes. It is a signatory to Japan's Stewardship Code and incorporates ESG factors into investment manager selection and monitoring.

### What currencies does the scheme prefer?

The scheme maintains exposure in JPY, USD and EUR.

### How liquid are the alternative holdings?

Alternative investments are categorized as low-liquidity assets.

## Related profiles

- [Whitehead Institute for Biomedical Research](https://altss.com/profile/whitehead-institute-for-biomedical-research)
- [Cypress Wealth Services](https://altss.com/profile/cypress-wealth-services)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/astellas-pharma-japan-pension-scheme

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology